• Reminder about Targeted Russian and Ukraine Sanctions

      • To
      • Chief Executive Officers, Chief Financial Officers, Chief Compliance Officers and Legal Counsel
      • From
      • Financial and Regulatory Surveillance Department, Clearing House Division
      • #
      • 14-04
      • Notice Date
      • 24 March 2014
      • Effective Date
      • 24 March 2014
    • FINANCIAL AND REGULATORY BULLETIN

       

       

      TO:                  Chief Executive Officers                                                                                #14-04

                              Chief Financial Officers                                                                              

                              Chief Compliance Officers

                              Legal Counsel

       

      DATE:             March 24, 2014 Chief Executive Officers, Chief Financial Officers, Chief Compliance Officers and Legal Counse

       

      SUBJECT:      Reminder about Targeted Russian and Ukraine Sanctions

       

       

      In consideration of developments arising from recent events in Ukraine, CME Group is reminding all clearing member firms about their obligations under CME, CBOT, and NYMEX Rule 981. Anti-Money Laundering and Economic Sanctions Compliance.  We also remind all others of their obligations to comply with applicable anti-money laundering and economic sanctions laws.

       

      As of the date of this Bulletin, targeted sanctions against certain individuals and entities in Russia and Ukraine have been issued by the United States, the EU, Canada, Australia, Japan, Switzerland and Lichtenstein stemming from these developments. 

       

      All parties should undertake due diligence efforts to assure that their activities do not involve or otherwise relate to parties designated under the new sanctions, including any entities that are owned or controlled by such designated parties.

       

      If you have any questions, please contact the Financial and Regulatory Surveillance Department at (312) 930-3230 or the Corporate Compliance Department at CME.Compliance.mailbox@cmegroup.com.